Cochrane reviews and systematic reviews of economic evaluations - Amantadine and rimantadine in the prevention and treatment of influenza

被引:7
|
作者
Jefferson, T
Demicheli, V
Rivetti, D
Deeks, J
机构
[1] UK Cochrane Ctr, Cochrane Vaccines Field, Surrey GU16 6JP, England
[2] Univ Pavia, Inst Med Stat, I-27100 Pavia, Italy
[3] ARPA, Environm Epidemiol Unit, Alessandria, Italy
[4] Inst Hlth Sci, Oxford, England
关键词
Influenza; Adis International Limited; Healthy Adult; Cochrane Review; Amantadine;
D O I
10.2165/00019053-199916001-00011
中图分类号
F [经济];
学科分类号
02 ;
摘要
Cochrane reviews provide standardised and regularly updated syntheses of evidence on the effects of healthcare interventions. We present the rationale for, and some of the results of, a Cochrane review of the effects of amantadine and rimantadine in the prevention and treatment of influenza. The estimates of effect will be incorporated into a decision-making model for tackling influenza in healthy adults (i.e. soldiers in the British Army). Our systematic review of the economics of influenza also provides the international context within which economic data can be interpreted and assessed as a preliminary to an economic evaluation comparing alternative prevention and treatment strategies. Systematic reviews provide powerful and relatively inexpensive evidence of effects and tolerability, which is more likely to convince decision-makers than evidence from single studies. Additionally, they can be used to focus clinical trial questions and provide strategic insight regarding the state-of-the-art knowledge of effects and economics of compounds in a specific field.
引用
收藏
页码:85 / 89
页数:5
相关论文
共 50 条
  • [21] Treatment of bacterial meningitis: An overview of Cochrane systematic reviews
    Prasad, Kameshwar
    Karlupia, Neha
    Kumar, Amit
    RESPIRATORY MEDICINE, 2009, 103 (07) : 945 - 950
  • [22] Summarising economic evaluations in systematic reviews: a new approach
    Nixon, J
    Khan, KS
    Kleijnen, J
    BRITISH MEDICAL JOURNAL, 2001, 322 (7302): : 1596 - 1598
  • [23] Quality of systematic reviews of economic evaluations in health care
    Jefferson, T
    Demicheli, V
    Vale, L
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (21): : 2809 - 2812
  • [24] SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS: HOW EXTENSIVE ARE THEIR SEARCHES?
    Wood, Hannah
    Arber, Mick
    Glanville, Julie M.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (01) : 25 - 31
  • [25] A summary of findings from the two Cochrane Systematic Reviews for the prevention and treatment of childhood obesity
    Edmunds, L
    Summerbell, C
    Waters, E
    Kelly, S
    Ashton, V
    CHILDHOOD OBESITY: FROM BASIC SCIENCES TO PUBLIC HEALTH, 2004, : 197 - 202
  • [26] Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study
    Jacobsen, Elisabet
    Boyers, Dwayne
    Avenell, Alison
    PHARMACOECONOMICS, 2020, 38 (03) : 259 - 267
  • [27] Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study
    Elisabet Jacobsen
    Dwayne Boyers
    Alison Avenell
    PharmacoEconomics, 2020, 38 : 259 - 267
  • [28] Maintaining relevance in HIV systematic reviews: an evaluation of Cochrane reviews
    Ingrid Eshun-Wilson
    Shahista Jaffer
    Rhodine Smith
    Samuel Johnson
    Paul Hine
    Alberto Mateo
    Anne-Marie Stephani
    Paul Garner
    Systematic Reviews, 8
  • [29] Maintaining relevance in HIV systematic reviews: an evaluation of Cochrane reviews
    Eshun-Wilson, Ingrid
    Jaffer, Shahista
    Smith, Rhodine
    Johnson, Samuel
    Hine, Paul
    Mateo, Alberto
    Stephani, Anne-Marie
    Garner, Paul
    SYSTEMATIC REVIEWS, 2019, 8 (1)
  • [30] The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews
    Michiels, Barbara
    Van Puyenbroeck, Karolien
    Verhoeven, Veronique
    Vermeire, Etienne
    Coenen, Samuel
    PLOS ONE, 2013, 8 (04):